These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2202801)
1. The c-erb B-2 proto-oncogene in human pancreatic cancer. Hall PA; Hughes CM; Staddon SL; Richman PI; Gullick WJ; Lemoine NR J Pathol; 1990 Jul; 161(3):195-200. PubMed ID: 2202801 [TBL] [Abstract][Full Text] [Related]
2. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract. Zhang X; Silva E; Gershenson D; Hung MC Oncogene; 1989 Aug; 4(8):985-9. PubMed ID: 2569708 [TBL] [Abstract][Full Text] [Related]
3. Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. Lemoine NR; Staddon S; Dickson C; Barnes DM; Gullick WJ Oncogene; 1990 Feb; 5(2):237-9. PubMed ID: 2181382 [TBL] [Abstract][Full Text] [Related]
5. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model. Hal DG; Stoica G Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494 [TBL] [Abstract][Full Text] [Related]
7. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Yamamoto T; Ikawa S; Akiyama T; Semba K; Nomura N; Miyajima N; Saito T; Toyoshima K Nature; 1986 Jan 16-22; 319(6050):230-4. PubMed ID: 3003577 [TBL] [Abstract][Full Text] [Related]
8. Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis. Wang DG; Johnston CF; Buchanan KD Cancer; 1997 Aug; 80(4):668-75. PubMed ID: 9264349 [TBL] [Abstract][Full Text] [Related]
9. Genetic basis of cancer of the pancreas: diagnostic and therapeutic applications. Sakorafas GH; Tsiotou AG Eur J Surg; 1994 Oct; 160(10):529-34. PubMed ID: 7849153 [TBL] [Abstract][Full Text] [Related]
10. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209 [TBL] [Abstract][Full Text] [Related]
11. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue]. Cui Q; Wang Z; Chen J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165 [TBL] [Abstract][Full Text] [Related]
12. Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma. Lee J; Jang KT; Ki CS; Lim T; Park YS; Lim HY; Choi DW; Kang WK; Park K; Park JO Cancer; 2007 Apr; 109(8):1561-9. PubMed ID: 17354229 [TBL] [Abstract][Full Text] [Related]
13. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients. Gorgoulis VG; Barbatis C; Poulias I; Karameris AM Mod Pathol; 1995 Sep; 8(7):758-64. PubMed ID: 8539234 [TBL] [Abstract][Full Text] [Related]
14. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Coussens L; Van Beveren C; Smith D; Chen E; Mitchell RL; Isacke CM; Verma IM; Ullrich A Nature; 1986 Mar 20-26; 320(6059):277-80. PubMed ID: 2421165 [TBL] [Abstract][Full Text] [Related]
15. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical localisation of the c-fos oncoprotein in pancreatic cancers. Lee CS; Charalambous D Zentralbl Pathol; 1994 Aug; 140(3):271-5. PubMed ID: 7947635 [TBL] [Abstract][Full Text] [Related]
17. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Tada M; Omata M; Kawai S; Saisho H; Ohto M; Saiki RK; Sninsky JJ Cancer Res; 1993 Jun; 53(11):2472-4. PubMed ID: 8495407 [TBL] [Abstract][Full Text] [Related]
18. Protein overexpression and gene amplification of c-erb B-2 in pulmonary carcinomas: a comparative immunohistochemical and fluorescence in situ hybridization study. Hirashima N; Takahashi W; Yoshii S; Yamane T; Ooi A Mod Pathol; 2001 Jun; 14(6):556-62. PubMed ID: 11406656 [TBL] [Abstract][Full Text] [Related]
20. Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene. Wallrapp C; Müller-Pillasch F; Solinas-Toldo S; Lichter P; Friess H; Büchler M; Fink T; Adler G; Gress TM Cancer Res; 1997 Aug; 57(15):3135-9. PubMed ID: 9242439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]